Provided by Tiger Trade Technology Pte. Ltd.

Adaptive Biotechnologies Corp

25.69
-0.3000-1.15%
Volume:907.30K
Turnover:23.26M
Market Cap:4.10B
PE:-62.46
High:25.99
Open:25.63
Low:25.10
Close:25.99
52wk High:26.16
52wk Low:12.00
Shares:159.76M
Float Shares:125.00M
Volume Ratio:0.53
T/O Rate:0.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4113
EPS(LYR):-0.3922
ROE:-38.76%
ROA:-4.12%
PB:28.72
PE(LYR):-65.51

Loading ...

Adaptive Biotechnologies Chief People Officer Francis Lo sells $340,043 common shares

Reuters
·
Apr 11

Adaptive Biotech CSO Harlan Robins sells 10,000 shares worth $148,500

Reuters
·
Apr 11

Adaptive Biotechnologies CEO Chad Robins disposes of USD 1.8 million common shares

Reuters
·
Apr 09

Adaptive Biotechnologies President, COO Julie Rubinstein disposes of USD 983,470 shares

Reuters
·
Apr 09

Adaptive Biotechnologies (ADPT) Is Up 15.3% After Beating Q4 Views And Striking Pfizer Deals

Simply Wall St.
·
Apr 06

Adaptive Biotechnologies President, COO Julie Rubinstein disposes common shares worth 0.6 million

Reuters
·
Apr 03

Adaptive Biotechnologies President and COO Julie Rubinstein; disposes of common shares worth $796,516

Reuters
·
Mar 27

Adaptive Biotechnologies launches clonoSEQ MRD test for blood cancers

Reuters
·
Mar 25

Adaptive Biotechnologies President and COO Julie Rubinstein disposes of USD 765,393 in common shares

Reuters
·
Mar 24

Assessing Adaptive Biotechnologies (ADPT) Valuation After Strong Q4 Results And MRD Growth

Simply Wall St.
·
Mar 20

Adaptive Biotechnologies President and COO Julie Rubinstein reports USD 766,000 common share disposal

Reuters
·
Mar 19

Adaptive Biotechnologies (ADPT) Is Down 11.9% After MRD-Led Earnings Beat And Tax-Driven Insider Sales - Has The Bull Case Changed?

Simply Wall St.
·
Mar 17

Adaptive Biotechnologies Chief People Officer Francis Lo Disposes of Common Shares

Reuters
·
Mar 14

Adaptive Biotechnologies Director Michelle Renee Griffin Disposes of Common Shares

Reuters
·
Mar 06

Adaptive Biotechnologies Chief Scientific Officer Harlan S. Robins Disposes of Common Shares

Reuters
·
Mar 05

Adaptive Biotechnologies CEO and Chairman Chad M. Robins Disposes of Common Shares

Reuters
·
Mar 04

Adaptive Biotech FY 2025 clonoSEQ test volume hits 105,587 (+39%)

Reuters
·
Feb 27

Does Post‑Earnings Analyst Optimism Around clonoSEQ Adoption Change The Bull Case For Adaptive (ADPT)?

Simply Wall St.
·
Feb 27

A Look At Adaptive Biotechnologies (ADPT) Valuation After Analyst Upgrades On Strong Q4 Earnings

Simply Wall St.
·
Feb 24